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Degradation kinetics of cold 
plasma-treated antibiotics and 
their antimicrobial activity
Chaitanya sarangapani1, Dana Ziuzina  1, patrice Behan2, Daniela Boehm1, 
Brendan F. Gilmore3, p. J. Cullen1,4 & paula Bourke1
Antibiotics, such as ofloxacin (OFX) and ciprofloxacin (CFX), are often detected in considerable 
concentrations in both wastewater effluents and surface water. This poses a risk to non-target 
organisms and to human health. The aim of this work was to study atmospheric cold plasma (ACP) 
degradation of antibiotics in water and meat effluent and to explore any residual antimicrobial activity 
of samples submitted to the plasma process. the results revealed that ACp successfully degraded the 
studied antibiotics and that the reaction mechanism is principally related to attack by hydroxyl radicals 
and ozone. According to the disk diffusion assay, the activity of both antibiotics was considerably 
reduced by the plasma treatment. However, a microdilution method demonstrated that CFX exhibited 
higher antimicrobial activity after ACp treatment than the corresponding control revealing a potentially 
new platform for future research to improve the efficiency of conventional antibiotic treatments. 
Importantly, short-term exposures to sub-lethal concentrations of the antibiotic equally reduced 
bacterial susceptibility to both ACP treated and untreated CFX. As a remediation process, ACP removal 
of antibiotics in complex wastewater effluents is possible. However, it is recommended that plasma 
encompass degradant structure activity relationships to ensure that biological activity is eliminated 
against non-target organisms and that life cycle safety of antibiotic compounds is achieved.
In recent years, there has been widespread and increased usage of antibiotics. Antibiotics are administered to 
humans and animals for control of bacterial infections, but are also widely used in cancer treatment and as growth 
promotion agents in some regions. Non-target environmental organisms are affected, resulting in risks of ecosys-
tem disruption1. In light of the need for careful antimicrobial stewardship due to the pervasive threat of antimi-
crobial resistant microorganisms, the environmental release of effluents containing antibiotics or their residues is 
of concern. Due to their poor degradation in sewage treatment plants (STPs), these antibiotics often find their way 
into water sources2. It has been observed that wastewater treatment plants (WWTPs) are not equipped with the 
specific facilities for the removal of many pharmaceuticals, especially antibiotics3. Fluroquinolones (FQs), such 
as ofloxacin (OFX) and ciprofloxacin (CFX), are broad-spectrum antibiotics, which are widely used for respira-
tory and bacterial infections4. Among other FQs, OFX and CFX are commonly detected in WWTPs effluents5, 
surface waters6,7 and sea waters8. The ranges of concentrations for CFX in WWTP effluents have been reported 
to be as high as 5.6 mg/L9 and in hospital effluents in a range of 3–87 mg/L10. Moreover, the low bio-degradability 
of quinolones makes conventional biological treatment ineffective for their removal. In conventional wastewater 
treatment, prolonged exposure to antibiotics could lead to the emergence and evolution of antibacterial resist-
ance11. Additionally, several reports conclude that these antibiotics and their residues pose a substantial toxic risk 
to aquatic organisms12. Current research efforts aim to develop new and efficient approaches to transform these 
chemical agents to pharmaceutically less active and more biodegradable species. Several authors have reported 
on the application of advanced oxidation technologies (AOP’s)13 including ozonation14, photocatalysis15, which 
have been proposed to remove antibiotic compounds11,16–18. Although these techniques, such as ozonation and 
combinations of AOPs lead to the degradation of many organic compounds in aqueous solutions, this does not 
necessarily mean that their total mineralization will be achieved19,20. Dantas et al.21 and Rosal et al.22 showed that 
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ozonation may generate oxidation intermediates and enhance the toxicity for aquatic life. Contact with ozonated 
water resulted in inhibition of the reproduction of the annelid Lumbriculus variegatus due to the formation of 
toxic oxidation by-products23. Recently, atmospheric cold plasma (ACP) has emerged as a novel AOP technology 
because of its efficient degradation efficiencies and environmental compatibility24. ACP is composed of several 
excited atomic, molecular, ionic, and radical species, coexisting with numerous reactive species, including elec-
trons, positive and negative ions, free radicals, gas atoms, molecules in the ground or excited state, UV light, 
shockwave and pyrolysis, which contribute to chemical and physical effects that can have an impact on organic 
pollutants decomposing them into more environmentally friendly compounds24–26. ACP has been efficient in the 
removal of dyes27, pesticides28,29, aflatoxins30 and pathogenic bacteria31,32. Currently, plasma technology is widely 
researched for the generation of functionalized solutions for biological decontamination of liquids. In plasma 
treated solutions reactive oxygen species (ROS), such as the hydroxyl (•OH·) radical, atomic oxygen (O), ozone 
(O3), and hydrogen peroxide (H2O2), play a major role in the inactivation processes33, although enhanced antimi-
crobial potential associated with an increase in nitric oxide (NO) radical concentration was also reported thereby 
providing new insight into the role of reactive nitrogen species (RNS)34. However, limited studies have been 
reported on the potential of plasma for the removal of antibiotics35,36. Lou et al.37 successfully achieved the degra-
dation of antibiotics from contaminated soil. The effectiveness of a dielectric barrier discharge (DBD) plasma to 
degrade antibiotics in water systems was investigated by Kim et al.38 and Magureanu et al.39. Few reports are pub-
lished on the identification of the degradation products and elucidation of the mechanisms governing their gen-
eration and their toxicity. It is important to know whether an intermediate product retains the biological effects of 
the parent compound or whether new and undesired biological effects are developed12. On the other hand, most 
of these studies on antibiotic degradation have been carried out in the absence of effluent organic matter that is 
generally present in wastewaters. Use of simulated or model effluents and identification of intermediate products 
and their toxicity studies could advance the suitability of cold plasma technology for wastewater treatment.
The objective of this work was to study the efficacy of atmospheric air plasma for the degradation of antibiotics 
in different liquid matrices, such as water and a model meat effluent. We aimed to elucidate the intermediate or 
transformed products in order to propose a reaction pathway. Furthermore, the antimicrobial property of the 
treated antibiotic solutions was also assessed with the potential for adaptive responses to any breakdown products 
in addition to exploring the possibility for enhanced biological safety.
Results and Discussion
Evaluation of degradation efficiency and kinetics. Ofloxacin (OFX) and ciprofloxacin (CFX) are 
among the most frequently detected antibiotics in the environment5–8. Although of the same chemical class, these 
antibiotics differ slightly in their molecular structure, which in the current research allowed reporting on the 
intrinsic factors influencing the efficacy of ACP for the removal of antibiotics from the environment.
Atmospheric air plasmas can generate many chemical reactions, which are responsible for generating various 
active chemical species at ambient conditions, such as negative and positive ions, neutral molecules (H2, O2, O3, 
and H2O2), and free radicals (•OH, •O, •H, and HO2•). Among these species, ozone (O3), hydrogen peroxides 
(H2O2), hydroxyl radicals (•OH), as well as RNS (peroxynitrites, nitrogen oxides) are generally identified as the 
main active species responsible for the degradation of antibiotics40–42, although the role of other reactive species 
may also be important in the degradation process through other chain reactions. In the current work, the con-
centration profiles revealed that the degradation depends on the applied voltage (Fig. 1). Increasing the voltage 
from 70 to 80 kV increased the plasma degradation efficacy of antibiotics in water from 75% to 89% for CFX and 
from 88 to 92% for OFX, respectively. This can be attributed to generation of more reactive species. It was also 
observed that the degradation of antibiotics was dependent on the treatment time with higher degradation rates 
achieved after longer plasma exposure. The degradation kinetics of antibiotics can be explained by a first-order 
kinetic model (model parameters can be found in Supplementary Table S1). The rates of reaction were increased 
from k = 0.039 to k = 0.054 min−1 with an increase in applied voltage from 70 kV to 80 kV.
The degradation efficacies and the reactive species generated are influenced by many factors, such as input 
energy, the nature of the gaseous atmosphere as well as pH, conductivity, temperature of the solution, chemical 
structure of the contaminant and the solution matrix43. In the current work, the influence of the solution matrix 
was studied to reflect more realistic challenges. The degradation efficacy of ACP was influenced by the presence 
of meat organic matter, which decreased the efficacy by 10% for all applied voltages as compared to the water sam-
ples. This is due to the competition between antibiotics and the organics present in the model meat effluent, where 
the plasma generated active species are consumed not only in reactions with antibiotics, but also in reactions with 
the organic matter and antibiotic degradants. During plasma treatment, the active species, such as ozone, hydro-
gen peroxide and hydroxyl radical, react with unsaturated bonds and aromatic rings of the organic compounds 
(proteins, carbohydrates, fat) leading to the splitting of bonds and the dissociation of the rings, following the 
Criegee mechanism44. The removal efficiency may be characterized by the amount of contaminant degraded per 
unit of energy (yield). The yield can be influenced by many factors, including system design, the type and the con-
centration of the compound. For the antibiotic solutions studied, a decrease in energy yield values was observed 
with increase in time and voltage. With increase in voltage, the energy yield has reduced from 328 × 10−6 to 
221 × 10−6 g/kW h and from 204 × 10−6 to 103 × 10−6 g/kW h for CFX and OFX in water, respectively.
ACP generates several oxidizing species: radicals (•OH, .H) and molecules (O3, H2O2, etc.) of which the 
hydroxyl radical is considered a very strong non-selective oxidant (Eo = 2.85 V/SHE). To identify the role of these 
radicals, experiments were conducted by adding radical scavengers. As shown in Fig. 2 the degradation efficiency 
of CFX and OFX in water was 88% and 91%, respectively. In the presence of the radical scavenger tertiary butyl 
alcohol (4 mmol l−1), an efficient hydroxyl radical quencher, the degradation efficiency dropped to 66% for CFX 
and 72% for OFX. The reaction of the hydroxy radical with most organic pollutants occurs either by hydro-
gen abstraction with saturated aliphatic hydrocarbons and alcohols, or electrophilic addition with unsaturated 
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hydrocarbons45. Interestingly, higher removal efficiencies were achieved in the presence of CCl4, which could 
quench •H in antibiotic solution. The removal efficiency increased to 90.5% for CFX and 93% for OFX by adding 
0.5 ml CCl4 to the antibiotic solutions. This may be attributed to a decrease in •H concentration, which inhibits 
the frequency of recombination between the hydrogen atom with the hydroxyl radical46.
Hydrogen peroxide (Eo = 1.77 V/SHE) is one of the most reactive species formed in gas-liquid plasma system. 
It is generally formed by the recombination of generated hydroxyl radicals in oxygen free water45,47. Hydrogen 
peroxide under ambient conditions is relatively stable in aqueous phosphate buffer solution with the reported 
stability of several weeks48. This can also be used as an efficient indicator of the •OH generation in the DBD con-
tained plasma reactor. In order to evaluate the efficacy of the DBD reactor, the formation of H2O2 in antibiotic 
solutions was quantified (Fig. 3). It can be observed that the concentration of H2O2 in the liquid phase generated 
by the DBD reactor is dependent on the treatment time and applied voltage. The concentrations of H2O2 ranged 
Figure 1. Degradation kinetics of antibiotic removal (a) OFX in water (b) OFX in meat effluent (c) CFX in 
water and (d) CFX in meat effluent at initial concentration of 10 mg l−1.
Figure 2. Effect of radical scavenger’s tertiary butanol alcohol (TBA) and Carbon tetra chloride (CCL4) on 
degradation of efficiencies of antibiotics in water at initial concentrations of 10 mg l−1.
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from 0.174 to 2.7 mM for antibiotics solutions in water with slightly higher values (0.21 to 3.6 mM) observed for 
antibiotics in the meat effluent. Similar results have been reported by previous authors49,50. Focusing on the degra-
dation of antibiotics by DBD plasma, Hama Aziz et al.43 reported that the presence of pharmaceuticals or organic 
matter can enhance the formation of H2O2.
The presence of oxygen in the gas atmosphere induces the production of reactive species like oxygen radicals 
and ozone. Ozone is one the most stable active species generated in DBDs with a high oxidation potential of 
2.02V51. The interaction between ozone and organic compounds can be either direct or indirect where decompo-
sition occurs through a series of reactions. It was believed that ozone formed in the gas phase during the discharge 
is dissolved in deionized water until saturation. In this study, the gas phase ozone concentrations measured after 
10 min of plasma treatment were found to be 2100 and 3200 ppm (within ± 10% errors) for applied voltages of 70 
and 80 kV, respectively. In our study, very low concentrations of dissolved ozone were achieved (data not shown). 
This is probably due to the rapid consumption of generated ozone during the degradation process of the antibi-
otics. Several authors have explained the formation of •OH radicals during the discharge in a chain reaction with 
ozone in water52. The lower dissolved ozone values can also be attributed to the consumption of ozone by the 
antibiotic itself and their intermediate products.
The variation of pH values for the solution after plasma treatment process is shown in Fig. 4. The pH value was 
lowered with increasing treatment time for all antibiotic solutions. After the first 5 min of treatment the pH values 
dropped to less than 4.5 and subsequent increases in treatment time resulted in a slow decline. This variation of 
pH values in the antibiotic solutions is caused by the formation of several specific acidic substances, such as nitric 
acid and nitrous acid during plasma treatment in air27. Also, a certain contribution to the pH variation during 
the plasma treatment may come from carboxylic intermediates, produced from the degradation of antibiotics. To 
confirm the acidification of the antibiotic solutions caused by air plasma the treated solutions were analyzed for 
the presence of nitrates, nitrites and several carboxylic acids. The concentrations of nitrate in the antibiotic-water 
solutions after 25 min of plasma treatment were found to be 0.98 mM and 2.38 mM for applied voltages of 70 
and 80 kV, respectively (Fig. 5). An increase in nitrate values was observed with increases in treatment time and 
applied voltage. Similarly, the formation of high nitrate concentrations in the solution were reported for gliding 
arc plasma treatments53,54. Such increases in nitrates cause a drop in pH. Moreover, no nitrites were detected in 
the present study, which is due to the easy conversion of nitrite to HNO2 under acidic conditions. Nitrates formed 
under acidic conditions undergo several reactions to form peroxynitrite acid55. Oxidative ability of reactive nitro-
gen species is lower than reactive oxygen species, as they are formed by consuming the stronger oxidant •OH, 
which in turn converts them to HNO356.
Figure 3. Variation of H2O2 concentration in plasma treated antibiotic solutions (a) OFX in water (b) OFX in 
meat effluent (c) CFX in water and (d) CFX in meat effluent.
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Several authors have reported that the ultimate oxidation by-products of pharmaceuticals are low-molecular 
weight carboxylic acids, such as oxalic acid, acetic acid, formic acid57,58. However, the toxicity of the degrada-
tion by-products may still be a matter of concern. It is known that ACP treatment of aqueous organic pollutant 
results in the formation of several intermediate products, such as carboxylic acids, formic acid and oxalic acid. 
The concentrations of formic and oxalic acids were determined using ion chromatograph and are presented in 
Fig. 6(A,B), respectively. It can be observed that the concentration of both organic acids increased with treatment 
time and all applied voltages. Similar results in the formation of organic acids as by-products have been reported 
by Vasquez et al.59 in plasma-treated aqueous antibiotic solutions. The formation of carboxylic acids resulted in 
slow mineralization and low total organic carbon (TOC) removal values after plasma treatment.
Degradation mechanism of antibiotics. The plasma degradation of organic contaminants takes place 
through several reactions. In the presence of air/oxygen the mechanism is not only based on the hydroxyl radi-
cal or ozone formation but also based on photo-oxygenation, photo-isomerisation or photo hydrolysis28,51. The 
carbon-centered radicals may yield peroxy radicals, which can be further decomposed to form corresponding 
oxidation products. Other mechanisms include the formation of superoxide radicals, which could further recom-
bine, rearrange or hydrolyze to final products. Like photolytic or photocatalytic processes, the organic contami-
nant during plasma treatment undergoes reactions through excitation or ionization60. These excited contaminants 
may also quench molecular oxygen with formation of singlet oxygen. It is reported that oxygen in its singlet 
oxygen state (E0 = 1.77 V) is more reactive compared to the molecular oxygen. Consequently, singlet oxygen is 
significantly more electrophilic61. This singlet oxygen can react rapidly with unsaturated carbon-carbon bonds 
neutral nucleophiles, such as sulfides62 and amines60, as well as with anions, and form an hydroperoxide as an 
intermediate compound.
In order to understand the antibiotic degradants present post plasma treatment, the changes of the LC–MS/MS 
chromatograms in full scan mode were examined. Samples taken at the time when the greatest range of 
by-products appeared were further analyzed by comparison to the literature to identify their molecular struc-
tures. The proposed pathways of these intermediate products are expected to include multiple routes due to the 
presence of several reactive sites in the parent compound but in the present study the occurrence of two oxidation 
mechanisms by both molecular ozone and hydroxyl radicals was considered. Based on the experimental data and 
literature survey the degradation of the quinolone group of antibiotics occurs as follows: the plasma generated 
active species, such as •OH and O3, attack the carboxyl group of the quinolone moiety at the first place, followed 
by subsequent attack of the piperazinyl substituent and oxazinyl substituent63. In our study, no transformation 
Figure 4. Evolution of pH in plasma treated antibiotic solutions (a) OFX in water (b) OFX in meat effluent (c) 
CFX in water and (d) CFX in meat effluent.
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products were found corresponding to the degradation of the oxazinyl group. These pathways are in line with 
work published by Carbajo et al.12.
The proposed degradation mechanism of OFX can be found in Supplementary Fig. S2. The MS/MS spectrum 
of OFX with a product ion at m/z 362.1 showed three significant product ions at m/z 261.1034, 318.2 and 344.1. 
The product at m/z 344.1 is due to the loss of H2O and the loss of 1- methylpiperzine group forms fragment ion at 
m/z 261.1. The MS spectrum of plasma treated samples showed two products ions at m/z 378 and m/z 394. These 
ions might be formed due to electrophilic reaction between plasma active species, such as ozone, and OFX. This 
electrophilic substitution reaction at the C12 position of OFX leads to TP1 (m/z 378) and a subsequent similar 
reaction at the C8 position may yield TP2 (m/z 394). Similar intermediate products have been identified by Tay 
and Madehi3 in the ozonation of OFX in water. In this study, another product with m/z 380 has been identified 
as TP3. The oxidation of quinolone moiety through breaking of double bonds leads to the formation of TP3. 
The peak identified in the MS/MS at m/z 354 is an intermediate product TP4, likely formed by the selective 
reaction of hydroxyl radical with an electron rich site. Formation of TP4 commences with hydrogen abstraction 
at C3 by •OH. Subsequent hydrogen abstraction by •OH forms the intermediate product. Therefore the inter-
mediate product formed undergoes intermolecular rearrangement through cleavage of C2-C3, which in turn 
undergoes a series of radical reactions and further hydroxylation to form TP43. In OFX degradation, pathway 2 
(Supplementary Fig. S3), the formation of TP5 (m/z 318) could be attributed to the attack of the carboxyl group 
of quinolone moiety by plasma generated •OH. This is due to the fact that the ionized OFX molecule possesses 
a negative charge at the carboxyl group, thus •OH is more prone to attack at carboxyl group than other spe-
cies59. The attack by plasma species, particularly •OH, on the piperazinyl substituent can evolve two degradation 
pathways, i.e., α-abstraction and β-abstraction63. The β-abstraction of OFX undergoes several reactions by the 
addition of hydroxyl groups. These series of reactions with the elimination of methylene groups leads to the for-
mation of TP6 (m/z 261). After the cleavage of the piperazinyl ring plasma active species likely attack the oxazinyl 
substituent, which finally leads to the formation of TP7 (m/z 221). The α-abstraction starts with the attack of the 
methylene group (demethylation) and the piperazine core. Demethylation of the piperazinyl ring leads to the 
formation of TP8. TP9 is attributed to ozone attack on the N4 atom. The main transformation product,TP10, 
is formed due to the addition of a hydroxyl radical at C7. It can also be considered as an oxidation product. The 
peak identified in the MS/MS spectra TP11 with m/z 376 is an intermediate product, likely to be a keto derivative, 
formed by plasma oxidative reactions12. TP12 (m/z 336) is proposed to be formed by the attack of the piperazine 
ring by plasma active species. The fragments at m/z 168(TPB) and m/z 157 (TPC) are also seen in the MS spec-
trum, as this could be formed through chain fragmentation of OFX. According to Shen et al.64, fluoroquinolones 
Figure 5. Variation of nitrate concentrations in plasma treated antibiotic solutions (a) OFX in water (b) OFX in 
meat effluent (c) CFX in water and (d) CFX in meat effluent.
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require the carboxyl group (-COOH) for antimicrobial activity. Therefore, it can be observed that the degradation 
of OFX leads to low molecular weight compounds such as m/z 157 with no antimicrobial activity.
The proposed degradation mechanism of CFX can be found in the Supplementary Fig. S4. The MS/MS spec-
trum of CFX with a product ion at m/z 362.1 showed four significant product ions at m/z 231.1, 245, 294, and 
314. Similar to OFX, several intermediate products (IP) have been identified from the MS/MS spectra of CFX. 
On the other hand, various peaks of by-products appeared whose intensity increased with time and which again 
Figure 6. (A) - Variations of concentrations of oxalic acid in plasma treated antibiotic solutions (a) OFX in 
water (b) OFX in meat effluent (c) CFX in water and (d) CFX in meat effluent. (B) - Variations of concentrations 
of formic acid in plasma treated antibiotic solutions (a) OFX in water (b) OFX in meat effluent (c) CFX in water 
and (d) CFX in meat effluent.
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disappeared with further increase in plasma doses35. This is due to the fact that CFX was first degraded into 
various intermediates, and then mineralized if sufficient treatment time is provided. The two major peaks IP1 
(m/z 330) has been identified in MS/MS spectra. This product might be formed by the substitution reaction 
of the fluorine atom by the hydroxyl radical. Similar structures has been proposed by Salma et al.65 in the pho-
tolytic and photo catalytic treatment of CFX. The formation of IP2 (m/z 346) can be proposed by the addition 
of a hydroxyl group at the piperazine ring of IP166. The degradants IP3(m/z 360) and IP4(m/z 332) are formed 
due to the addition reactions of plasma treatment. It can be hypothesized that plasma species attack the piper-
azine ring of CFX or it could undergo photo-oxygenation yielding peroxy radicals (peroxy-piperazine rings). 
This intermediate product undergoes an initial attack of •OH via hydrogen abstraction leading to the opening 
of the piperazine ring, which is converted to the ketone derivative IP4 and further oxidation results in carboxylic 
derivative65. Difluorination of CFX and addition reactions similar to IP3 would result in the formation of IP5 
(m/z 344), subsequent reaction would result in IPA (m/z 245). The intermediate products identified in pathway II 
(Supplementary Fig. S5) were found in most of the samples, which occur especially under neutral and acidic con-
ditions with preservation of the fluorine atom65,66. The product IP6 (m/z 348) could be the hydroxylation product 
of CFX, formed via direct reaction between plasma active species, such as ozone and hydroxyl radicals. The for-
mation of monohydroxy BPA was further confirmed by the fragmented peak ions at m/z 330 and m/z 245. This 
reaction further proceeded to yield IP7 (m/z 364). The formation of IP7 is attributed to the attack of •OH formed 
and the addition of an hydroxyl radical to the piperazine ring67. The spectra at m/z 346 is an intermediate product 
IP8, likely to be a keto derivative, formed by the selective reaction of ozone with an electron rich site without any 
cleavage of the piperazine ring65,67. This IP8 on further oxidation follows a ring opening mechanism forming 
dicarboxylic acids. A similar degradation mechanism has been observed in air plasma treatment of endocrine 
disruptors49,57. The product IP9 follows a similar reaction to IP3 but with the elimination of the fluorine atom. The 
cleavage of the piperazine ring followed by the loss of CO yields the product IP10. This oxidation follows a frag-
mentation pattern to yield IP11 (m/z 306) and IP12 ( m/z 263). Previously Torniainen et al.68 identified similar 
products to the final degradation product of CFX at low pH. According to the proposed reaction pathway, plasma 
treatment of antibiotics OFX and CFX may not undergo complete degradation. However, the primary structure 
was transformed into low molecular weight compounds upon higher plasma doses. Overall it can be observed 
that reactions at the piperazine group occur by molecular ozone where reactions at quinolone moiety are pri-
marily a consequence of radical reactions. The changes in the piperazine group may not decrease the activity, but 
changes in the carbonyl and carboxyl groups at the quinolone moiety, which are essential for binding at the DNA 
gyrase thereby decreasing the overall activity of antibiotics.
Antibacterial activity. The degradation of antibiotics should be accompanied with the loss of biological 
function. The residual antibacterial activity of CFX and OFX dissolved in either water or meat effluent was exam-
ined using a disk diffusion assay and measuring the inhibition zone diameter (mm) for E. coli, B. atrophaeus and 
P. aeruginosa (Figs S6 and S7). It should be noted that all controls resulted in no inhibition zone formed around 
the disks and that the disk assay involving P. aeruginosa was not valid due to the resistance of this microorganism 
to studied antibiotics at the concentration obtained on disks (~0.2 μg disk−1). In both cases the inhibition zone 
diameter was recorded as 6 mm, which was equal to the diameter of the disk. In general, the efficacy of ACP 
treatment for the degradation of antibiotics was influenced by the duration of the treatment and was affected by 
the type of antibiotic and the sample matrix. The antibacterial activity of OFX and CFX is linked to the presence 
of carboxylic and carbonyl groups in the quinolone molecule. Thus, the antimicrobial activity of both antibiotics 
dissolved in water was significantly reduced (p < 0.05) after either 15 or 25 min of treatment as was recorded for 
the microorganisms tested (Fig. 7A). A lower degradation ability of ACP was observed when the antibiotics were 
dissolved in the meat effluent (Fig. 7B). Moreover, in this case the effect of the type of antibiotic on ACP degra-
dation ability was more apparent, with CFX exhibiting higher resistance to ACP than OFX. The CFX mechanism 
of degradation also supports the results from the observed antibacterial activity. It was found that the quinolone 
moiety of OFX was completely transformed. However, the CFX transformation was reserved only for piperazine, 
fluorine substituents, with the core quinolone structure remaining intact. Therefore, the efficacy of plasma treat-
ment for antibiotic degradation depends on the susceptibility of the core structure of the chemical compound to 
oxidation pathways. Plasma treatment may not sufficiently oxidize or mineralize the quinolone ring of CFX, but 
can cause significant transformations to the auxiliary functional groups, which could also decrease the antibac-
terial activity. A relationship between degradation efficiency and antimicrobial activity reduction was observed.
To confirm the degradation efficacy of plasma, the effect of the longest treatment time (25 min) on the anti-
microbial activity of the antibiotics suspended in a simple sample matrix (water) was quantitatively assessed 
using the broth microdilution method. This estimated the MIC values for the three microorganisms selected 
(Supplementary Table S7). However, a relatively low agreement between the two tests was found in the case of the 
remaining antimicrobial activity of CFX. According to the MIC values for E. coli, B. atrophaeus and P. aeruginosa, 
the CFX samples exhibited a higher antimicrobial activity after ACP treatment than the corresponding untreated 
control. In contrast, higher MICs were recorded for ACP treated OFX as compared with MICs of the untreated 
control for all microorganisms tested. This indicates that the reduction of the antimicrobial activity of this anti-
biotic (OFX) is due to the plasma treatment, which is in agreement with the disk diffusion assay. Therefore, for 
OFX, the degradation processes did not generate by-products with a greater antimicrobial activity than the parent 
compound. These observations were also demonstrated by De Witte et al.69 for ozonation and by Paul et al.70 for 
UVA photo catalysis.
The increased activity of CFX highlights the generation of compounds more toxic to cells due to the plasma 
exposure, which was not reflected with the disk diffusion assay. Such discrepancy between the two techniques 
could be due to the decreased stability of the generated by-products that exhibit antimicrobial properties in the 
disk diffusion assay or impaired diffusion capacity of these compounds into the agar. The antimicrobial potential 
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of the water (antibiotic diluent) subjected to plasma treatment was tested using a two-fold microdilution method 
to examine its potential microbial toxicity. Plasma treated water was not toxic to cells at concentration below 
12.5% for P. aeruginosa and 6.2% for E. coli and B. atrophaeus that do not correspond to the dilutions at which 
MICs for the two antibiotics were reached (Supplementary Table S7). These results demonstrated that the reten-
tion of antimicrobial potential of treated antibiotics could not be attributed to the antimicrobial properties of the 
plasma treated water.
Unintentional exposure of microorganisms to sub-inhibitory concentrations of biocides in the environment 
can lead to the development of antimicrobial resistance, which is a global healthcare problem71. Because of the 
demonstrated increase in the antimicrobial potency of ACP treated CFX, a study on bacterial adaptation to CFX 
was conducted. For E. coli, the tendency of bacterial adaptation after repeated exposure to untreated CFX was 
observed, with a significant, 8-fold increase in MIC recorded (p < 0.05). Importantly, there was only 1.5-fold 
increase in MIC value noted in the case of ACP treated antibiotic (Fig. 8A), which is a useful observation indicat-
ing synergistic effects of antibiotics and plasma treatment. Such an effect could improve the efficiency of conven-
tional antimicrobials and/or antibiotic treatments. A significant reduction (p < 0.05) in susceptibility to both ACP 
treated and untreated CFX was observed for B. atrophaeus and P. aeruginosa, with a 4-fold increase in the MIC 
values found (Fig. 8B,C, respectively). This study revealed that short-term exposure to sub-lethal concentrations 
of antibiotics present in effluents, whether they were treated with cold plasma or not, equally reduced antibiotic 
susceptibility, which could potentially select for bacterial populations with stable genetic mutations. Therefore, 
it is recommended that cold plasma as an AOP for industrial effluents that may contain antibiotics or residues is 
optimized for complete loss of biological activity or is combined with a separate process to ensure life cycle safety.
In conclusion, we have determined the optimum operating conditions for the degradation of antibiotics (OFX 
and CFX) using an atmospheric air plasma DBD plasma reactor. The results revealed that the rates of the degra-
dation order were dependent on treatment time, voltage as well as sample matrix. The degradation rate was more 
Figure 7. Antimicrobial activity of antibiotics treated in (A) water and (B) meat effluent after 0, 15 and 25 min 
of treatment tested against E. coli and B. atrophaeus. Results represent mean values of measured inhibition zone 
diameter, mm (n = 6). Different letters indicate a significant difference between the diameters (p < 0.05) of each 
bacterial group and type of antibiotic studied. Vertical bars represent standard deviation.
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pronounced for OFX than CFX due to differences in their chemical structure of antibiotics. The reduced TOC 
removal values indicates that the antibiotics and organic matter are degraded to smaller molecules such as NO3, 
acetic and formic acids. The degradation pathway includes the oxidation of piperazinyl and quinolone moieties. 
With the decrease of antibiotic concentration, antibacterial activity also decreased according to results obtained 
by using the disk diffusion assay, showing that there is a relationship between degradation and antibacterial activ-
ity reduction. There was no major difference observed between the adaptations of the microorganisms to treated 
or untreated antibiotics. Plasma treatment could be a promising addition to existing advanced oxidation pro-
cesses, as efficient degradation of antibiotics in industrial effluents can be achieved. However, further studies are 
required in order to investigate the potential for genetic mutation responses as well as eco-toxicological effects of 
Figure 8. Minimum inhibitory concentration of either ACP treated or untreated control ciprofloxacin for E. coli  
(A), B. atrophaeus (B) and P. aeruginosa (C) exposed to corresponding antibiotic sample or TSB (TSB-control) 
for up to ten consecutive exposures. Results represent mean values of estimated MIC, mg l−1 (n = 9). Different 
letters indicate a significant difference between MIC values (p < 0.05) obtained for each bacterial group. Vertical 
bars represent standard deviation.
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plasma treated antibiotic solutions in the form of individual compounds as well as complex mixtures, when such 
solutions and their degradants are released into the environment.
Methods
Materials. Analytical grade standards of ofloxacin (OFX) and ciprofloxacin (CFX) of purity (>98%), HPLC 
grade methanol, acetonitrile, ethyl acetate, ammonium hydroxide solution (32%) puriss p.a. (NH4OH), acetic 
acid (AcOH), formic acid (HCOOH), sodium acetate (NaOAc), ammonium formate, tertiary butanol alcohol 
(TBA), carbon tetrachloride (CCl4) and LC-MS grade water were obtained from Sigma-Aldrich (Ireland).
sample preparation. A fresh model effluent was prepared before each experimental run using procedure 
of Barrera et al.72. The raw synthetic meat effluent consisted of distilled water, commercial meat extract powder 
1950 mg l−1; glycerol (C3H8O3), 200 mg l−1; ammonium chloride (NH4Cl), 360 mg/l and sodium chloride (NaCl) 
50 mg l−1. The model effluent was used to overcome the inherent variability found in commercial effluent com-
position. Large particulate matter was removed by filtering the model effluent through a Whatman (UK) filter 
paper and a 0.45 μm membrane (Millipore). Because of the structural characteristics and persistence in the envi-
ronment, ofloxacin (OFX) and ciprofloxacin (CFX) were selected in this work. Each antibiotic (OFX and CFX) 
was dissolved in methanol to obtain a standard stock solution with the concentration 1000 mg l−1. The prepared 
stock solution was either diluted in water or spiked with the model effluent to obtain a minimum concentration 
of antibiotic 10 mg l−1.
Atmospheric air cold plasma treatment. The high voltage in package ACP DBD system employed for 
this work is described in Sarangapani et al.73 and was fully characterized in Moiseev et al.74 and Patil et al.75. The 
schematics of the system is presented in Supplementary Fig. S8. For each experiment 25 ml of water or meat 
effluent spiked with antibiotics at initial concentration of 10 mg l−1 was subjected to ACP treatment. Atmospheric 
air was used as the working gas. Plasma treatment was performed at variable voltage (70–80 kV) and treatment 
duration (5–25 min). Treatment was carried out in duplicate at ambient temperature (~18 °C). The temperature 
increase inside the container and at the surface of the samples due to plasma treatment was <5 °C. After process-
ing, containers were stored at room temperature of ~18 °C for 24 h in line with our previous findings that post 
treatment retention time is useful for biocontrol. This treatment approach allows extended contact time of the 
generated and contained chemical reactive species with the samples. Control samples were not plasma treated. 
Ozone concentrations were measured using short-term ozone detection tubes obtained from Gastec (Product No. 
18 M, Gastec, Japan), while dissolved ozone measurements were carried out according to the procedure of Bader76.
Analytical Methods. Standard curves for the antibiotics were established using standard solutions ranging 
between 0.01 mg l−1 and 10 mg l−1. The linear correlation coefficients (r2) were 0.997 and 0.998 for OFX and CFX, 
respectively. The plasma treated effluents were firstly extracted by solid-phase extraction (SPE) according proce-
dure of Sarangapani et al.49. Antibiotics quantification was performed using a HPLC system (Waters, Ireland). The 
mobile phase consisted of 70% acetonitrile and of 30% 0.03 M phosphate buffer solution at pH 2.7, and the flow 
rate was set at 1 ml min−1. The detector wavelength was set at 277 nm. Chromatographic data was collected and 
processed using Empower2 software (Waters, Ireland).
The intermediates from plasma discharge were analyzed by LC-MS/MS coupled to a triple quadrupole instru-
ment operating in electrospray ionization (ESI) mode (Agilent, Ireland) Milford, MA, USA). Separation was 
carried out on Phenomenex Gemini-Nx C18 column (Phenomenex, U.K.), 5 μm particle size (250 mm × 4.6 mm) 
maintained at 30 °C. A binary gradient system was used to separate analytes. Mobile phase A consisted of 50 mM 
formic acid and 2 mM ammonium formate in water, while mobile phase B consisted of 50 mM formic acid and 
2 mM ammonium formate in acetonitrile. The gradient profile was linear from 30% B to 50% B over 3 min and 
100% B at 5 min, then 2 min at 30% B followed by 3 min for re-equilibration at 30% B. The LC-MS/MS system 
and data was processed by agilent mass hunter software. A full scan mode was used to acquire MS/MS spectra 
of the intermediates with a scan range of m/z 80–500. The organic acids in the effluent were quantified by an ion 
chromatograph (ICS 3000, Dionex, USA) at 30 °C. Hydrogen peroxide and nitrate concentrations were deter-
mined according to procedure of Boehm et al.48 and Lu et al.53 Briefly, hydrogen peroxide concentration was 
determined by oxidation of potassium iodide (KI) to iodine and measured spectrophotometrically at 405 nm 
using 96 well plate. Either plasma treated samples, untreated controls or standard curve samples (50 μl), phos-
phate buffer (50 μl) and KI (100 μl) were added to each well. After 20 min incubation at room temperature absorb-
ance was measured. A standard curve with known hydrogen peroxide concentration was included on the same 
plate to convert absorbance into peroxide concentration. Nitrite concentration was measured by Griess reagent 
(Sigma-Aldrich) in 96 well plates. Griess reagent (50 μl) was added to either treated, untreated or standard sam-
ples (50 μl). After 30 min incubation, absorbance was measured at 548 nm. A range of nitrite solutions of known 
concentrations were prepared to make the nitrite calibration curve, which was used to convert absorbance into 
nitrite concentrations. Nitrate concentrations were determined photometrically by 2,6-dimethyl phenol (DMP) 
using the Spectroquant nitrate assay kit (Merck 1.09713, Darmstadt, Germany) and calculated using a NaNO3 
standard curve. Tests were performed using 96 well plates. In addition, the contribution of radical scavengers to 
the degradation efficiency of antibiotics was investigated by adding tBuOOH (tertiary butyl alcohol is considered 
as an affective hydroxyl radical scavenger) and CCl4 (hydrogen radical scavenger) to the aqueous antibiotics 
solutions77.
Degradation kinetic modeling study and data analysis. The removal efficiencies (η) of antibiotics 
were calculated according to the following equation: η = (C0 − C)/C0 × 100, where η is removal efficiency of each 
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antibiotic, C is the concentration of antibiotic at time ‘t’ and C0 the initial concentration of the antibiotic. Plasma 
degradation of antibiotics in aqueous media can be described by the following equation: C = C0 exp (−kt), where 
‘k’ is the degradation rate constant (min−1) of the reaction and ‘t’ is the treatment time (min).
Antimicrobial activity. Disk diffusion assay. To determine the remaining antimicrobial activity of tested 
antibiotics (OFX and CFX), standard disk diffusion assay was utilized involving three single species test micro-
organisms, namely Escherichia coli ATCC 25922, Bacillus atrophaeus var. niger (Sportrol®/Namsa®, VWR 
International, ATCC 9372) and Pseudomonas aeruginosa ATCC 27853, obtained from School of Food Science 
and Environmental Health of the Dublin Institute of Technology. Each bacterium was inoculated in tryptic soy 
broth (TSB, Scharlau Chemie, Spain) and incubated overnight at 37 °C. The density of each overnight culture was 
adjusted to McFarland 0.5. Resulting cell suspensions were further used for inoculation of tryptic soy agar (TSA, 
Biokar Diagnostics, France). Either ACP treated (15 and 25 min) or non-treated antibiotic solutions were filtered 
(0.2 μm pore size) and 20 μl aliquots were deposited on sterile discs (diameter 6 mm, Whatman®), while either 
ACP treated or untreated sterile deionized water and meat effluent served as a control. The disks were dried inside 
the laminar flow biosafety cabinet and placed on inoculated TSA plates. Following incubation for 24 h at 37 °C the 
zone of inhibition (diameter, mm) produced around the disks was measured at the point where no growth was 
observed. Experiments were performed in triplicate and replicated twice (n = 6).
Minimum inhibitory concentration (MIC). MIC of either treated (ACP treatment − 25 min) or untreated anti-
biotic solutions in water for E. coli, B. atrophaeus and P. aeruginosa were determined using broth microdilution 
method78. Controls included each antibiotics concentration without bacterial cells (blank), TSB and bacterial cells 
(positive control) and two-fold diluted plasma treated water in TSB with final concentration of plasma treated 
water ranging from 50–0.01%. Plates were incubated for 24 h at 37 °C. MICs of either treated or untreated antibi-
otic for three microorganisms were determined as the lowest concentration showing no turbidity as comparing 
to corresponding blank controls. Plasma treatment experiments were replicated three times and two biological 
replicates were included in each plate (n = 6). The lowest antibiotic concentration that inhibited the growth of 
the microorganism was detected by the lack of visual turbidity (matching corresponding blank control) and was 
designated as MIC79.
Bacterial adaptation study. To study the possible development of resistance to ACP treated CFX, three biolog-
ical replicates of each microorganism (E. coli, B. atrophaeus and P. aeruginosa) and three independently treated 
antibiotic in water (ACP treatment − 25 min) were used (n = 9). Overnight cultures were adjusted to ~6 log10 
colony forming units (CFU) ml−1 in TSB. Either treated or untreated antibiotics were filter sterilized (pore size 
0.2 μm) and twofold dilution series were prepared in 96 well plates with highest concentration corresponding to 
the double of the lowest MIC value established and the lowest concentration corresponding to 1/8 MIC. Bacterial 
cell suspensions (50 μl) were added to resulting concentrations of each antibiotic (50 μl). TSB without antibiotics 
was used as a control. Plates were incubated for 24 h at 37 °C. After incubation, MICs for each antibiotic were 
recorded and bacterial samples from the well containing sub-inhibitory concentration corresponding to ¼MIC 
were streaked on TSA80. The TSA plates were incubated for 24 h at 37 °C. Using isolated colonies the concen-
tration of cells was visually adjusted with saline (0.85% NaCl) to a turbidity equivalent to the McFarland 0.5 
standard. Bacterial suspensions were further diluted in TSB to a final cell concentration of ~6 log10 CFU ml−1. 
Again, aliquots of bacterial inoculum (50 μl) were dispensed into the wells containing doubling dilutions of each 
antibiotic with final absorbance measured at 600 nm corresponding to ~0.05. Viable count of the inoculum sus-
pension using TSB without antibiotics was performed each time to ensure that final concentration of the inocula 
in the wells corresponds to ~5 log10 CFU ml−1. This procedure was repeated for ten consecutive cycles. Bacterial 
cells recovered after 1st, 5th and 10th exposures to sub-lethal doses of antibiotics were used to determine the MIC 
values, which were compared with MICs determined for cells exposed to TSB.
statistical analysis. Statistical analysis was performed using IBM SPSS statistics 21 Software (SPSS Inc., 
Chicago, USA). The values of the inhibition zone diameter measured for either untreated control or ACP treated 
for 15 and 25 min antibiotic samples for E. coli, B. atrophaeus and P. aeruginosa and MIC of CFX for each bacte-
ria in bacterial adaptation study were subjected to Analysis Of Variance (ANOVA). Means of the diameters and 
MICs were compared according to the method of Fisher’s Least Significant Difference-LSD at the 0.05 level for 
each type of bacteria and antibiotic group.
Data Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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